236 results on '"Colombo, Eleonora"'
Search Results
2. Clinical usefulness of the Verbal Fluency Index (VFI) in amyotrophic lateral sclerosis
3. Reliable change indices for the Italian version of the Montreal Cognitive Assessment (MoCA) in non-demented Parkinson’s disease patients
4. Further insights into anti-IgLON5 disease: a case with complex clinical presentation
5. The value of routine blood work-up in clinical stratification and prognosis of patients with amyotrophic lateral sclerosis
6. Correction: Clinimetrics and feasibility of the Italian version of the Frontal Assessment Battery (FAB) in non-demented Parkinson’s disease patients
7. Transcranial static magnetic stimulation for amyotrophic lateral sclerosis: a bicentric, randomised, double-blind placebo-controlled phase 2 trial
8. Phosphorylated tau in plasma could be a biomarker of lower motor neuron impairment in amyotrophic lateral sclerosis
9. Frontotemporal-spectrum disorders and functional independence in non-demented ALS patients
10. Clinical usability of the Story-Based Empathy Task (SET) in non-demented ALS patients
11. Equating norms between the ALS Cognitive Behavioral Screen (ALS-CBS™) and the Edinburgh Cognitive and Behavioural ALS Screen (ECAS) in non-demented ALS patients
12. Clinimetrics and feasibility of the Italian version of the Frontal Assessment Battery (FAB) in non-demented Parkinson’s disease patients
13. Relationship between cerebrospinal fluid/serum albumin quotient and phenotype in amyotrophic lateral sclerosis: a retrospective study on 328 patients
14. Cognitive rehabilitation and aerobic exercise for cognitive impairment in people with progressive multiple sclerosis (CogEx): a randomised, blinded, sham-controlled trial
15. Motor, cognitive and behavioural profiles of C9orf72 expansion-related amyotrophic lateral sclerosis
16. Correlation between clinical phenotype and electromyographic parameters in amyotrophic lateral sclerosis
17. Correction to: Motor, cognitive and behavioural profiles of C9orf72 expansion-related amyotrophic lateral sclerosis
18. Correction to: Correlation between clinical phenotype and electromyographic parameters in amyotrophic lateral sclerosis
19. Total Synthesis of an Epothilone Analogue Based on the Amide‐Triazole Bioisosterism.
20. QSM-detected iron accumulation in the cerebellar gray matter is selectively associated with executive dysfunction in non-demented ALS patients.
21. Longitudinal feasibility of the Montreal Cognitive Assessment (MoCA) in non-demented ALS patients
22. Association of APOE genotype and cerebrospinal fluid Aβ and tau biomarkers with cognitive and motor phenotype in amyotrophic lateral sclerosis.
23. Association of Clinically Evident Eye Movement Abnormalities With Motor and Cognitive Features in Patients With Motor Neuron Disorders
24. An exploratory study on counterfactual thinking in amyotrophic lateral sclerosis
25. Targeting Ovarian Cancer with Chalcone Derivatives: Cytotoxicity and Apoptosis Induction in HGSOC Cells
26. The value of routine blood work-up in clinical stratification and prognosis of patients with amyotrophic lateral sclerosis
27. Synthesis and Characterization of Edaravone Analogues as Remyelinating Agents and Putative Mechanistic Probes
28. Cognitive rehabilitation and aerobic exercise for cognitive impairment in people with progressive multiple sclerosis (CogEx): a randomised, blinded, sham-controlled trial
29. Immobilized Rose Bengal as Photocatalyst for Metal‐Free Thiocyanation of Azaheterocycles under Continuous Flow Conditions
30. Rising evidence for neurological involvement in COVID-19 pandemic
31. Tetraphenylethylene-Based Photoluminescent Self-Assembled Nanoparticles: Preparation and Biological Evaluation
32. The impact of upper motor neuron involvement on clinical features, disease progression and prognosis in amyotrophic lateral sclerosis
33. Correction: Clinimetrics and feasibility of the Italian version of the Frontal Assessment Battery (FAB) in non-demented Parkinson’s disease patients
34. Bulbar involvement and cognitive features in amyotrophic lateral sclerosis: a retrospective study on 347 patients
35. Frontotemporal-spectrum disorders and functional independence in non-demented ALS patients.
36. 2-Hydroxyoleic Acid as a Self-Assembly Inducer for Anti-Cancer Drug-Centered Nanoparticles
37. Regional spreading pattern is associated with clinical phenotype in amyotrophic lateral sclerosis
38. Single task-level, 2SD-based cutoffs for the Italian version of the Edinburgh Cognitive and Behavioral ALS screen (ECAS).
39. Enantioselective Organocatalytic Addition of Nitromethane to Trifluoromethyl Aryl Ketimines Promoted by Electron‐Rich Bifunctional Iminophosphoranes
40. Phenotypic correlates of serum neurofilament light chain levels in amyotrophic lateral sclerosis
41. Association of the risk factor UNC13A with survival and upper motor neuron involvement in amyotrophic lateral sclerosis
42. Standardization of the Italian ALS-CBS™ Caregiver Behavioral Questionnaire
43. Cannabidiol as Self-Assembly Inducer for Anticancer Drug-Based Nanoparticles
44. Serum levels of glial fibrillary acidic protein in patients with amyotrophic lateral sclerosis
45. Dehydroroyleanone as a Building Block for a Drug Delivery Platform Based on Self-Assembled Nanoparticles: Structural Studies and Chemical Modification
46. Motor, cognitive and behavioural profiles of C9orf72 expansion-related amyotrophic lateral sclerosis
47. Correlation between clinical phenotype and electromyographic parameters in amyotrophic lateral sclerosis
48. Squalene-Based Nano-Assemblies Improve the Pro-Autophagic Activity of Trehalose
49. Upper motor neuron dysfunction is associated with the presence of behavioural impairment in patients with amyotrophic lateral sclerosis
50. Ecological Validity of the Montreal Cognitive Assessment in Non-Demented Parkinson’s Disease Patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.